NO20011537D0 - Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes - Google Patents

Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes

Info

Publication number
NO20011537D0
NO20011537D0 NO20011537A NO20011537A NO20011537D0 NO 20011537 D0 NO20011537 D0 NO 20011537D0 NO 20011537 A NO20011537 A NO 20011537A NO 20011537 A NO20011537 A NO 20011537A NO 20011537 D0 NO20011537 D0 NO 20011537D0
Authority
NO
Norway
Prior art keywords
diabetes
prevention
treatment
chemokine receptor
peptide vaccines
Prior art date
Application number
NO20011537A
Other languages
English (en)
Other versions
NO20011537L (no
Inventor
Maureen Howard
Shrikant Deshpande
Walter Ferlin
Subhashini Arimilli
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20011537D0 publication Critical patent/NO20011537D0/no
Publication of NO20011537L publication Critical patent/NO20011537L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20011537A 1998-09-30 2001-03-26 Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes NO20011537L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/164,186 US6171590B1 (en) 1998-09-30 1998-09-30 Chemokine receptor peptide for inducing an immune response
PCT/US1999/022992 WO2000018431A1 (en) 1998-09-30 1999-09-30 Chemokine receptor peptide vaccines for treatment and prevention of diabetes

Publications (2)

Publication Number Publication Date
NO20011537D0 true NO20011537D0 (no) 2001-03-26
NO20011537L NO20011537L (no) 2001-05-28

Family

ID=22593363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011537A NO20011537L (no) 1998-09-30 2001-03-26 Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes

Country Status (10)

Country Link
US (2) US6171590B1 (no)
EP (1) EP1117429A4 (no)
JP (1) JP2002525338A (no)
KR (1) KR20010082217A (no)
CN (1) CN1328470A (no)
AU (1) AU6285399A (no)
CA (1) CA2345978A1 (no)
IL (1) IL142283A0 (no)
NO (1) NO20011537L (no)
WO (1) WO2000018431A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000506365A (ja) * 1996-01-11 2000-05-30 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｇタンパク質ケモカインレセプターｈｓａｔｕ６８
US7888466B2 (en) * 1996-01-11 2011-02-15 Human Genome Sciences, Inc. Human G-protein chemokine receptor HSATU68
US6140064A (en) * 1996-09-10 2000-10-31 Theodor-Kocher Institute Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3
AU2001249546A1 (en) * 2000-03-27 2001-10-08 Corixa Corporation Methods for treating disease with antibodies to cxcr3
FR2817260A1 (fr) * 2000-11-29 2002-05-31 Centre Nat Rech Scient Peptides ayant des proprietes anti-inflammatoires, leurs utilisations et les compositions les contenant
US20050250175A1 (en) * 2002-08-02 2005-11-10 Takehiko Nomura Bacterial cell wall skeleton component preparaion
AU2005219322B2 (en) * 2004-03-09 2008-09-18 Kyoto University Pharmaceutical Composition Comprising CXCR3 Inhibitor
WO2005102369A1 (ja) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. 細菌細胞壁骨格成分を含有する製剤
EP2004675A1 (en) 2006-03-16 2008-12-24 Protagonists Ltd. Combination of cytokine and cytokine receptor for altering immune system functioning
CN100450552C (zh) * 2006-05-26 2009-01-14 中国医学科学院医学生物学研究所 Ⅰ型糖尿病疫苗及其构建方法
EP2164508B1 (en) 2007-06-04 2014-01-08 Rappaport Family Institute for Research in the Medical Sciences Agents for the treatment of inflammatory diseases and methods of using same
WO2010041150A2 (en) * 2008-10-10 2010-04-15 Protagonists Ltd. Pharmaceutical peptides for the treatment of inflammatory diseases
WO2010103517A1 (en) * 2009-03-12 2010-09-16 Rappaport Family Institute For Research In The Medical Sciences Soluble compositions for the treatment of cxcr3-ligand associated diseases
WO2014186842A1 (en) * 2013-05-22 2014-11-27 Monash University Antibodies and uses thereof
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537764B1 (en) * 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
WO1997025340A1 (en) 1996-01-11 1997-07-17 Human Genome Sciences, Inc. Human g-protein chemokine receptor hsatu68
ATE360689T1 (de) 1996-09-10 2007-05-15 Kocher Theodor Inst Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
SE9801098D0 (sv) 1998-03-30 1998-03-30 Astra Pharma Prod Receptors

Also Published As

Publication number Publication date
NO20011537L (no) 2001-05-28
CA2345978A1 (en) 2000-04-06
WO2000018431A1 (en) 2000-04-06
US20010006942A1 (en) 2001-07-05
AU6285399A (en) 2000-04-17
CN1328470A (zh) 2001-12-26
IL142283A0 (en) 2002-03-10
US6171590B1 (en) 2001-01-09
KR20010082217A (ko) 2001-08-29
EP1117429A4 (en) 2002-11-20
JP2002525338A (ja) 2002-08-13
EP1117429A1 (en) 2001-07-25

Similar Documents

Publication Publication Date Title
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
NO20063000L (no) Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav.
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
HUP0103147A3 (en) Pharmaceutical composition comprising glp1 and their use for the treatment of functional dyspepsia and/or irritable bowel syndrome
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
DK1035865T3 (da) HIV-1-Tat eller derivater deraf til profylaktisk og terapeutisk vaccination
IS5070A (is) Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það
NO20011537D0 (no) Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes
NO20002831D0 (no) Medikament i myk tablettform og fremgangsmÕter for fremstilling av dette
NO985484L (no) FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
IT243536Y1 (it) Apparecchio ortodontico per l'espansione e la contrazione ortodonticae ortopedica del mascellare superiore.
GB9720797D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
IT1305069B1 (it) Polsino per la prevenzione e il trattamento della sindrome del tunnelcarpale e metodo per la sua applicazione
IL133136A0 (en) Use of leptin antagonists for the treatment of diabetes
NO983512D0 (no) Midler for behandling og forhindring av AIDS
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
NO20001551L (no) Takkledningselement, system og anvendelse av elementene
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
EP0954324A4 (en) CYCLIC PEPTID VACCINES FOR DIABETES TREATMENT AND PREVENTION
NO996264L (no) Behandling av diabetes med tiazolidindion og sulfonylurea

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application